Advertisement

Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 3504 | Ordered by Date (descending)
1 2 3 ... 34 35 36  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Curetis–Goetzpartners: investor conference, 201806 supply service Curetis presents at Goetzpartners Healhlcare Day 2018 in London 2018-06-22
Bruker Corp–William Blair: investor conference, 201806 supply service Bruker presents at William Blair Annual Growth Stock Conference in Chicago 2018-06-13
Sartorius–Siemens: automation technology, 201806– collab long-term using Siemens automation for SSB’s bio production offerings 2018-06-12
RSP Systems–SEVERAL: investment, 201806 financing round Series B first closing €6.5m incl family offices + private investors 2018-06-11
Bruker Corp–Leucadia: investor conference, 201806 supply service Bruker presents at Jefferies Healthcare Conference in New York 2018-06-07
Evotec–Deutsche Bank: investor conference, 201806 supply service Evotec presents at dbAccess Berlin Conference 2018-06-07
Roche–Microbiotica: microbiomics, 201806– collab multi-year up to $534m r+d + commerc of markers + targets + treatments for IBD w Genentech 2018-06-06
Roivant–Oxford BioMedica: Parkinson’s gene therapy, 201806– license ww excl to OXB-102 $30m upfront + $812.5m milestones to Axovant Sciences 2018-06-06
Evotec–Leucadia: investor conference, 201806 supply service Evotec AG presents at Jefferies 2018 Global Healthcare Conference NYC 2018-06-05
Gilead–Hookipa Biotech: therapeutic vaccine technology, 201806– collab + license $10m upfront r+d immunotherapies against HIV + HBV 2018-06-05
Secarna–MC Services: public relations, 201806 service existent by MC Services 2018-06-04
Sierra Sensors–Bruker Corp: investment, 201806 acquisition €na of Sierra Sensors GmbH by Bruker 2018-06-04
Univ Birmingham–Thermo Fisher: mass spectrometer, 201806 supply existent early customer Orbitrap ID-X Tribrid MS system at PCB 2018-06-04
Arix Bioscience–Evotec: drug discovery, 201805–202304 collab partnership LAB591 for early-stage projects out of Fred Hutchinson Cancer Center 2018-05-31
Arix Bioscience–Fred Hutchinson: drug discovery, 201805–202304 collab partnership LAB591 for early-stage projects out of Fred Hutch with Evotec 2018-05-31
Evotec–Fred Hutchinson: drug discovery, 201805–202304 collab partnership LAB591 for early-stage projects out of Fred Hutch with Arix Bioscience 2018-05-31
TxCell–Lonza: cell therapy contract manufacturing, 201805– supply of TX200 for clinical studies by Lonza production site in Geleen (NL) 2018-05-31
Univ Tübingen–ERS Genomics: CRISPR technology, 201804– license €na to NMI + NMI TT Pharmaservices to expand custom cell-based research services 2018-05-31
F-Star–Denali Therapeutics: investment, 201805 acquisition of F-Star Gamma Ltd via early exercise of option for asset-centric vehicle 2018-05-30
Five Prime–Roche: companion diagnostics, 201805– collab €na to develop IHC CDx assays for two cancer antibody candidates 2018-05-30
Ultra Scientific–Agilent: investment, 201805– acquisition of all business assets €na of Ultra Scientific by Agilent 2018-05-30
Aldeyra Therapeutics–Centogene: genomic services, 201805– collab identification of genetic markers for Sjögren-Larsson Syndrome using CentoMD 2018-05-29
Celgene–Evotec: drug discovery services, 201805– strategic RnD collab expansion $6m to incl additional cell lines 2018-05-29
High-Tech Gründerfonds–Bayer: investment, 201805 Bayer invests in HTGF III 2018-05-29
High-Tech Gründerfonds–Boehringer: investment, 201805 BIVF invests in HTGF III 2018-05-29
High-Tech Gründerfonds–SEVERAL: investment, 201805 2nd closing of HTGF III €71.5m bringing total fund size to €316.5m 2018-05-29
Treeway–Trophic Communications: public relations, 201805 service existent by Trophic 2018-05-29
Lunaphore–Vitro (ES): in situ hybridisation, 201805– collab developm ISH protocols for RNA + DNA targets in tissue 2018-05-24
Medigene–SEVERAL: investment, 201805 private placement €32.3m 2.23m new shares at €14.5/share to institutional investors 2018-05-24
Evotec–I’rom Group: iPSC technology, 201805– license non-excl for iPSCs produced with Sendai virus vector technology from ID Pharma 2018-05-23
Lava Therapeutics–Trophic Communications: public relations, 201805 service existent by Trophic 2018-05-23
Orphazyme–Centogene: biomarker discovery, 201805– collab service biomarkers for Gaucher disease clinical trial monitoring 2018-05-23
Evotec–Berenberg: investor conference, 201805 supply service Evotec presents at Berenberg European Conference USA in Tarrytown 2018-05-22
Celgene–Evotec: drug discovery services, 201805– strategic RnD collab $65m upfront for cancer drugs 2018-05-21
Pierre Fabre–Roche: companion diagnostics, 201805– collab extension for developm of IHC CDx assay for ADC W0101 2018-05-18
Centogene–Informa: investor conference, 201805 supply service Centogene presents at BioEquity Europe 2018 in Ghent 2018-05-16
Evotec–Bank of America: investor conference, 201805 supply service Evotec presents at BoAML Global Healthcare Conference Las Vegas 2018-05-16
Bluebird Bio–Medigene: TCR technology, 201805– collab strategic alliance expansion incl $8m one-time payment 2018-05-14
Curetis–Informa: investor conference, 201805 supply service Curetis presents at BioEquity Europe 2018 in Ghent 2018-05-14
Polyneuron–SEVERAL: investment, 201805 seed financing round CHF3.1m led by EVA Basel + incl Zürcher Kantonalbank + private investors 2018-05-14
Valerius Biopharma–Catalent: contract manufacturing, 201805– collab cell line developm + manufacturing of speciality biosimilars using GPEx technology 2018-05-14
Armo BioSciences–Lilly: investment, 201805– acquisition $1.6b cash tender offer at $50/share by Eli Lilly 2018-05-10
Memo Therapeutics–Redalpine: investment, 201805 financing round Series A2 totalling CHF5m incl existing investor Redalpine Venture Partners 2018-05-09
Memo Therapeutics–Schroders: investment, 201805 financing round Series A2 totalling CHF5m incl new investor Schroder Adveq 2018-05-09
Memo Therapeutics–SEVERAL: investment, 201805 financing round Series A2 CHF5m incl Schroder Adveq + investiere.ch + Redalpine Ventures et al. 2018-05-09
Memo Therapeutics–Verve Capital Partners: investment, 201805 financing round Series A2 totalling CHF5m incl new investor investiere.ch 2018-05-09
Memo Therapeutics–Zürcher Kantonalbank: investment, 201805 financing round Series A2 totalling CHF5m incl existing investor ZKB 2018-05-09
PHAST–Eurofins: investment, 201805 acquisition of PHAST GmbH by Eurofins Scientific 2018-05-09
Bruker Corp–Deutsche Bank: investor conference, 201805 supply service Bruker presents at Deutsche Bank Annual Health Care Conference 2018-05-08
Evotec–Deutsche Bank: investor conference, 201805 supply service Evotec presents at Deutsche Bank 43rd Annual Health Care Conference in Boston 2018-05-08
Pieris–Deutsche Bank: investor conference, 201805 supply service Pieris presents at Deutsche Bank 43rd Annual Health Care Conference in Boston 2018-05-08
Waters–Deutsche Bank: investor conference, 201805 supply service Waters presents at Deutsche Bank 43rd Annual Health Care Conference in Boston 2018-05-08
InflaRx–LifeSci: public relations, 201805 service existent IR by LifeSci Advisors + Media US by LifeSci Public Relations 2018-05-03
SmartDyeLivery–SEVERAL: investment, 201805 financing round from new investor STIFT + existing investors bm|t + Sparkasse Jena-Saale-Holzland 2018-05-03
Unisensor (BE)–Scienion: print/spotting technology, 201805 collab use of sciFlexarrayer techn for Extenso milk analysis platform 2018-05-03
Evotec–ERS Genomics: CRISPR technology, 201804– license €na to expand Evotec’s CRISPR-based service offering from ERS Genomics Ltd 2018-05-02
Genohm–Agilent: investment, 201805 acquisition €na of Genohm by Agilent 2018-05-02
InflaRx–SEVERAL: investment, 201805 primary public offering $51m+$7.65m w 1.5m+225k common shares at $34/share 2018-05-02
AdvanceCor–SEVERAL: investment, 201805 financing round €6m led by MIG AG + incl Occident Group + Bayern Kapital + HTGF + KfW Bank + founders 2018-05-01
Crescendo Biologics–SEVERAL: investment, 201805 financing round Series B €57m led by Andera Partners 2018-04-30
NovellusDx–SEVERAL: investment, 201804 financing round $6m incl investors Helsinn + BCIF + Windham Venture Partners 2018-04-30
Roche–4D Molecular Therapeutics: gene delivery technology, 201804– collab expansion to develop + commercialise ophthalmic gene therapy products 2018-04-30
Roivant–SEVERAL: investment, 201804 financing round $40.5m of Datavant led by Roivant Sciences + Travis May 2018-04-30
Universal Patient Key–Roivant: investment, 201804 acquisition of UPK by Datavant 2018-04-30
Curetis–Global Corporate Finance: investment, 201804–202103 equity facility $10m solely at Curetis request up to 36 months at pre-agreed floor pricing 2018-04-27
Curetis–SEVERAL: investment, 201804 capital increase €4.1m offering of 854k new ordinary shares at €4.8/share to qualified EU + US investors 2018-04-27
Polyphor–Consilium: public relations, 201804 service existent international media relations by CSC 2018-04-27
Boehringer–Topas Therapeutics: immuno modulatory compounds, 201804– collab €na multi-y research + option agreem 2018-04-24
Merck (DE)–P&G: investment, 201804 acquisition €3.4b in cash of Merck’s consumer healthcare by P&G 2018-04-19
AiCuris–Max Planck: anti-infectives, 2018004– collab discovery of antibiotics + virostatic compounds extending existent collab with MPI-MP 2018-04-18
Curetis–Van Lanschot: investor conference, 201804 supply service Curetis presents at Kempen Life Sciences Conference 2018 in Amsterdam 2018-04-18
Tizona Therapeutics–Minapharm: biopharma production, 201804– supply service cell line + process developm + production of therap antibody by ProBioGen 2018-04-18
Anasys Instruments–Bruker Corp: investment, 201804 acquisition of Anasys by Bruker 2018-04-17
DKSH–Bruker Corp: analytical instruments, 201804– distribution multi-product line of Bruker AXS in KR + AU + NZ + SG + ID by DKSH Technology 2018-04-17
Enterprise Therapeutics–Novartis: investment, 201804 financing round Series B totalling £29m ($41m) incl co-lead investor Novartis Venture Fund 2018-04-12
Enterprise Therapeutics–SEVERAL: investment, 201804 financing round Series B £29m ($41m) co-led by Versant Ventures + NVF 2018-04-12
Knauer–Microsaic: mass spectrometry, 201804– collab integration of Microsaic’s compact MS techn in Knauer’s LC platform 2018-04-12
Petra Pharma–Evotec: drug development services, 201804– supply service €na support developm of Petra-01 through to IND 2018-04-11
AveXis–Novartis: investment, 201804– acquisition $8.7b in cash of AveXis Inc by Novartis for $128/share ANNOUNCED 2018-04-09
Grünenthal–Univ Leuven: pain drugs, 201804– collab r+d non-opioid pain drugs with CD3 + LICR 2018-04-09
Polyphor–SEVERAL: investment, 201804–201805 IPO CHF165m at SIX Swiss Exchange at CHF38/share 2018-04-09
Allecra Therapeutics–HC Wainwright: investor conference, 201804 supply service Allecra presents at HC Wainwright Global Life Sciences Conference 2018-04-08
Curetis–HC Wainwright: investor conference, 201804 supply service Curetis presents at HC Wainwright Global Life Sciences Conference in Monte Carlo 2018-04-08
Boehringer–OSE Immunotherapeutics: antibody cancer drug, 201804– collab + license ww OSE-172 €30m upfront+short-term + €1.1b milestones + royalties 2018-04-04
Bravos Biosciences–Arsanis: therapeutic antibody, 201804– license pre-clin develop ww excl to ASN200 program + option further developm to BB100 LLC 2018-04-04
LCF Rothschild–Andera Partners: investment, 201804 management buy-out of EdRIP by employees + renaming to Andera Partners 2018-04-04
Brainomix–Boehringer: investment, 201804 financing round totalling £7m incl new + co-investor BIVF 2018-04-03
Brainomix–SEVERAL: investment, 201804 financing round £7m led by Parkwalk Advisors + incl BIVF + Chimera Partners + Oxford Univ 2018-04-03
Arsanis–Needham: investor conference, 201803 supply service Arsanis presents at Annual Needham Healthcare Conference in NY 2018-03-27
Medigene–Needham: investor conference, 201803 supply service Medigene presents at Annual Needham Healthcare Conference in NY 2018-03-27
Novartis–GSK: investment, 201803– acquisition $13b of 36.5% stake of Novartis in OTC joint venture giving GSK 100% ownership 2018-03-27
PITBUL project–EU (govt): grant, 201803–2020 Horizon 2020 grant €3.8m to develop ultrafast PoC tuberculosis diagnostic platform 2018-03-24
MorphoSys–SEVERAL: investment, 201803–201804 US IPO $208m+$31m with 8.3m+1.245m ADSs at $25.04/ADS + listing at Nasdaq Global Market 2018-03-22
Aton–Grifols: investment, 201803– acquisition 100% of Haema for €220 on a debt free basis by Grifols from Aton GmbH 2018-03-20
Novartis–Harvard Univ: drug delivery technology, 201803– collab develop biomaterial systems for delivery of cancer immuntherapies NIBR + Wyss + Dana 2018-03-20
Robert Bosch Hospital–bio.logis: genetic software, 201803– supply implementation of bio.logis GIMS IT platform at RBK 2018-03-20
Bruker Corp–KAUST: magnet resonance technology, 201803– collab establ KAUST-Bruker Center of Excellence in Magnetic Resonance 2018-03-18
KAUST–Bruker Corp: magnetic resonance technology, 201803 supply 500 MHz super wide-bore MRI spectrometer at KAUST-Bruker CoE in Magnetic Resonance 2018-03-18
KAUST–Bruker Corp: magnetic resonance technology, 201803 supply 900 MHz wide-bore NMR spectrometer at KAUST-Bruker CoE in Magnetic Resonance 2018-03-18
KAUST–Bruker Corp: magnetic resonance technology, 201803 supply 950 MHz NMR spectrometer at KAUST-Bruker CoE in Magnetic Resonance 2018-03-18
1 2 3 ... 34 35 36  next pagenext page



Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group Bio-Europe 2018 Copenhagen Denmark November 600x60px

» top